Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Salhi, C. Haenebalcke, S. Perez-Bogerd, D. M. Nguyen Dang, R. Colman, K. Y. Vermaelen, T. L. Malfait, V. F. Surmont, G. Van Maele, V. Ninane, J. P. van Meerbeeck, E. Derom (Ghent, Bruges, Brussels, Liege, Belgium). Effect of resistance training (RT) on maximal exercise capacity (MEC) and muscle force (MF) in patients (pts) with radically treated (RaT) intrathoracic cancer. Eur Respir J 2013; 42: Suppl. 57, 5070

Member's Comments

No comment yet.

Related content which might interest you: Impact of lung resection surgery on peak oxygen uptake (VO2peak) and muscle strength in non-small cell lung cancer patients (NSCLC) Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases Year: 2015 Site of first progression (PR) differs between stage III NSCLC patients treated with simultaneous radiochemotherapy (RTCT) and those treated with radiotherapy (RT) alone following induction chemotherapy (CT) Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Muldisciplinary conference (MDC), oncological program (OP) and practice guidelines (GL): The experience of the lung cancer (LC) clinic of a cancer hospital Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Oncogenic drivers (OD) and matched targeted agents (TA): Impact on overall survival in patients with lung adenocarcinoma (LA)? Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Use of Bode index (BI) in patients with COPD undergoing inpatient pulmonary rehabilitation (IPR) after lung resection (LR) for non small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 70s Year: 2006 Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung: LUX-Lung 8 (LL8), a phase III trial Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015 Effects of Yoga and aerobic exercise training on functional capacity, respiratory muscle strength, and quality of life in breast cancer survivors Source: Annual Congress 2013 –Exercise and physiotherapy in non-COPD conditions and in the assessment of healthy subjects Year: 2013 The role of radiotherapy (RTH) in long-term survival limited disease (LD) small cell lung cancer (SCLC) patients (pts) treated in the National TB and Lung Diseases Research Institute Source: Eur Respir J 2002; 20: Suppl. 38, 463s Year: 2002 Afatinib (A) vs gefitinib (G) as first-line treatment (tx) for patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC: LUX-Lung 7 Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Breathlessness-inducing exercise in advanced cancer populations. Which measures to use as functional status declines? Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 Skeletal muscle strength and functional exercise capacity in patients undergoing surgery for lung cancer Source: International Congress 2014 – Physiotherapy and physical activity in respiratory conditions Year: 2014 A phase III trial comparing concomitant radiochemotherapy (RT-CT) with cisplatin (P) and docetaxel (D) as induction versus consolidation in patients with locally advanced unresectable non-small cell lung cancer (NSCLC). An ELCWP study Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015 Preliminary results of first year of application of cardiopulmonary exercise test (CPET) in resection lung surgery in Navarra (Spain) Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Effects of a 6 week whole-body vibration training (WBVT) in stable COPD patients: A randomized clinical trial Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception Year: 2016 Early versus late pulmonary rehabilitation (PR) following treatment for inoperable nonsmall cell lung cancer (NSCLC) Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013 Analysis of overall survival (OS) in two large open-label phase III studies (LUX-Lung 3 [LL3] and LUX-Lung 6 [LL6]) comparing afatinib with chemotherapy (CT) in patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring common (Del19/L858R) epidermal growth factor receptor mutations (EGFR mut) Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Single institution experience in advanced non-small cell lung cancer (NSCLC) patients (pts) with erlotinib (Tarceva®) within a large extended access programme* (EAP) Source: Eur Respir J 2006; 28: Suppl. 50, 772s Year: 2006 Inspiratory muscle training (IMT) in interstitial lung disease (ILD) - A pilot study Source: International Congress 2016 – Physiotherapy management of the ill but spontaneously-breathing adult patient Year: 2016 Respiratory training (RT) modifies the breathing pattern (BP) toward a more efficient one during maximal incremental exercise. Source: International Congress 2019 – Exercise testing and respiratory muscles in various diseases Year: 2019 Asthma control (AC) 1 year after pulmonary rehabilitation (PR) Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011